Pre-Angel Venture Studio

Expertise First.
We turn promising tech
into profitable companies.

You have great science but need to quickly
translate that into revenue.
That's where we help.

We identify and grow early biotech, medtech, and deeptech startups,
including independent innovators and university spinouts.

We bring network, technical, and commercial expertise,
and we work at-risk for equity.

How We Help

Capital Second.
Expertise First.

We help scientists and inventors turn new technology into funded, growing companies, whether the path runs through SBIRs, angels, corporate partners, or straight to market.

We're experienced operators embedded in your company — not coaches, not investors at arm's length. We work at-risk for equity, so we only win when you do.

What Longleaf offers that AI can't:

AI can organize, analyze, and draft. But a strong prototype alone rarely wins the attention of people who can make it succeed, and AI can't change that. Longleaf brings real-world knowledge of how partners, funders, and customers evaluate new technology, plus trusted relationships that can turn early innovation into successful businesses.

Biotech Medtech Deep Tech Pre-Angel Equity for Expertise

Not an Accelerator

No cohorts. Every engagement is bespoke — we embed in your business.

Not a VC Fund

No LPs, no conflicts. We invest our most scarce resource: expert time.

Not a Consulting Firm

No hourly fees. We work at-risk for equity.

We Are A Trusted Studio Partner

We bring network, domain knowledge, and hands-on execution — to strengthen your firm, protect your IP, and drive commercialization.

How It Works

Our Three-Phase Approach

1
Phase One

Commercialization Partners

We embed in your organization to validate market opportunity and define the go-to-market strategy.

3–6 Months  ·  Equity for expertise
2
Phase Two

Gap Funding Bridge

We provide or facilitate pre-angel capital to bridge the hardest financing gap in deep-tech.

6–12 Months  ·  $25K–$100K capital
3
Phase Three

Commercial Scale

We activate our network to drive revenue and position the company for institutional investment or acquisition.

4–12 Months  ·  Revenue generation

This approach lets us work step-by-step with you,
for as long (or as little) as we all agree is best.

The Founding Team

The Team

Ted Benson

Ted Benson

Founder and CEO

Biotech and global pharma operator — lab to market, building technical teams, and scientific portfolio management.

Biotech Startups Global Pharma Lab to Market Technical Teams Portfolio Management GSK Catalent Diviner
Rosanna Stokes

Rosanna Stokes

Founder and Managing Partner

Market creation, commercialization, M&A, and federal funding — translating early-stage technology into commercial strategy.

Market Creation Commercialization M&A Federal Funding Corporate Partnerships GE Emerald Materials Dot Metrics

Is Your Company a Fit?

We carefully select the Carolinas-based firms we help. We start with a free introductory process — you get to know us, we get to know you. Fill out the form below to begin that process.